Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $4.28 USD
Change Today -0.04 / -0.93%
Volume 5.8K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank Litvack M.D., FACC

Executive Chairman and Chairman of Compensation Committee,Capricor Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 6 different organizations across 9 different industries.

See Board Relationships


Dr. Frank Litvack, M.D., FACC, serves as Director of Strategy and Alternative Investments at Pura Vida Investments. Dr. Litvack has been Managing Director of the General Partner of Calmedica Capital LP since 2001. Dr. Litvack is Co-Founder of Reprise Medical Technologies. He is Co-Founder and Chairman of Entourage Medical Technologies. Dr. Litvack has over 25 years of academic and industry experience. He is a serial entrepreneur. He has a wealth of business building ...

Read Full Background

Corporate Headquarters*

8840 Wilshire Boulevard
Beverly Hills, California 90211

United States

Phone: 310-358-3200
Fax: --

Board Members Memberships*

Chairman of the Board
Member of The Board of Directors
Executive Chairman and Chairman of Compensation Committee


McGill University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options1,893,190
Total Number of Options1,893,190

Total Compensation*

Total Annual Cash Compensation$120,000
Total Calculated Compensation$120,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAPR:US $4.28 USD -0.04


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAPRICOR THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at